Published in Ethn Dis on January 01, 2005
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol (2015) 2.17
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomarkers Prev (2010) 1.66
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat (2012) 1.66
Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol (2010) 1.45
Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention. Breast Cancer Res (2013) 0.85
My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR). Med Decis Making (2015) 0.80
Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study. BMC Cancer (2015) 0.79
Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake. Ecancermedicalscience (2015) 0.77
African American women's perspectives on breast cancer: implications for communicating risk of basal-like breast cancer. J Health Care Poor Underserved (2013) 0.76
Physician and Patient Barriers to Breast Cancer Preventive Therapy. Curr Breast Cancer Rep (2016) 0.75
Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review. Hered Cancer Clin Pract (2017) 0.75
Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30
Risk and the pregnant body. Hastings Cent Rep (2009) 4.63
Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA (2002) 4.52
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med (2011) 3.52
Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med (2011) 3.00
Cost utility of prenatal diagnosis and the risk-based threshold. Lancet (2004) 3.00
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med (2003) 2.72
Models in the development of clinical practice guidelines. Ann Intern Med (2014) 2.18
Risks, values, and decision making surrounding pregnancy. Obstet Gynecol (2007) 2.11
Mode of delivery: toward responsible inclusion of patient preferences. Obstet Gynecol (2008) 1.57
Using Geographic Information Systems (GIS) to assess outcome disparities in patients with type 2 diabetes and hyperlipidemia. J Am Board Fam Med (2010) 1.54
Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. Obstet Gynecol (2004) 1.52
Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview. Ethn Dis (2005) 1.52
Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause (2015) 1.47
Decrease in urinary incontinence management costs in women enrolled in a clinical trial of weight loss to treat urinary incontinence. Obstet Gynecol (2012) 1.45
A community-based study of acne-related health preferences in adolescents. Arch Dermatol (2008) 1.44
Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Cancer (2005) 1.43
Economic Evaluation of Telemedicine for Patients in ICUs. Crit Care Med (2016) 1.40
Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol (2010) 1.32
Sexual function and aging in racially and ethnically diverse women. J Am Geriatr Soc (2009) 1.11
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09
Translation of health surveys using mixed methods. J Nurs Scholarsh (2010) 1.09
Quality and equality in obstetric care: racial and ethnic differences in caesarean section delivery rates. Paediatr Perinat Epidemiol (2009) 1.08
Medical adherence research: time for a change in direction? Med Care (2004) 1.06
What parents want to know about the storage and use of residual newborn bloodspots. Am J Med Genet A (2014) 1.04
Networked for change? Identifying obstetric opinion leaders and assessing their opinions on caesarean delivery. Soc Sci Med (2003) 1.01
Training the translational research teams of the future: UC Davis-HHMI Integrating Medicine into Basic Science program. Clin Transl Sci (2013) 1.00
Demanding patient or demanding encounter?: A case study of a cancer clinic. Soc Sci Med (2009) 0.98
L-BLP25 vaccine plus letrozole induces a TH1 immune response and has additive antitumor activity in MUC1-expressing mammary tumors in mice. Clin Cancer Res (2012) 0.98
Obstetricians' attitudes and beliefs regarding umbilical cord clamping. J Matern Fetal Neonatal Med (2013) 0.97
Public reporting and pay-for-performance: safety-net hospital executives' concerns and policy suggestions. Inquiry (2007) 0.97
Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol (2009) 0.97
Global Solar UV Index: Australian measurements, forecasts and comparison with the UK. Photochem Photobiol (2004) 0.96
Social and familial context of prenatal genetic testing decisions: are there racial/ethnic differences? Am J Med Genet C Semin Med Genet (2003) 0.94
Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women. J Bone Miner Metab (2006) 0.93
Patient preferences for different severities of and treatments for overactive bladder. Female Pelvic Med Reconstr Surg (2011) 0.93
Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies. Cancer Invest (2003) 0.93
Medicine or Surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding. Control Clin Trials (2004) 0.92
Assessment of demand for prenatal diagnostic testing using willingness to pay. Obstet Gynecol (2004) 0.91
Finding autonomy in birth. Bioethics (2009) 0.91
Management of the low-grade abnormal Pap smear: What are women's preferences? J Fam Pract (2002) 0.90
Changing patterns of addiction and public aid receipt: tracking the unintended consequences of welfare reform. J Health Polit Policy Law (2006) 0.90
The Association of Expanded Access to a Collaborative Midwifery and Laborist Model With Cesarean Delivery Rates. Obstet Gynecol (2015) 0.90
Effects of changes in prenatal aneuploidy screening policies in an integrated health care system. Obstet Gynecol (2013) 0.90
Establishing electronic health record competency testing for first-year residents. J Grad Med Educ (2013) 0.89
Development and validation of a sexual functioning measure for use in diverse women's health outcome studies. Am J Obstet Gynecol (2008) 0.89
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89
Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women. Am J Obstet Gynecol (2008) 0.89
Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract (2012) 0.87
UVR emissions from solaria in Australia and implications for the regulation process. Photochem Photobiol (2010) 0.86
Understanding risk, patient and provider preferences, and obstetrical decision making: approach to delivery after cesarean. Semin Perinatol (2010) 0.86
Do personal and societal preferences differ by socio-demographic group? Health Econ (2007) 0.86
Decision making for primary cesarean delivery: the role of patient and provider preferences. Semin Perinatol (2012) 0.85
Comparison and correlates of three preference-based health-related quality-of-life measures among overweight and obese women with urinary incontinence. Qual Life Res (2011) 0.85
Tracking Health Data Is Not Enough: A Qualitative Exploration of the Role of Healthcare Partnerships and mHealth Technology to Promote Physical Activity and to Sustain Behavior Change. JMIR Mhealth Uhealth (2016) 0.85
Why quantile regression makes good sense for analyzing economic outcomes in medical research. Acad Emerg Med (2012) 0.85
Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol (2009) 0.84
Abortion attitudes of pregnant women in prenatal care. Am J Obstet Gynecol (2005) 0.84
Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med (2016) 0.84
Identifying a "range of reasonable options" for cervical cancer screening. Obstet Gynecol (2015) 0.83
Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility. Health Econ (2003) 0.83
Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: resource use in the Medicine or Surgery (Ms) trial. Am J Obstet Gynecol (2006) 0.83
Long-Term Outcomes of the Total or Supracervical Hysterectomy (TOSH) Trial. Female Pelvic Med Reconstr Surg (2010) 0.82
Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Am J Obstet Gynecol (2002) 0.82
Variation in Women's Understanding of Prenatal Testing. Obstet Gynecol (2015) 0.82
A cost-effectiveness analysis comparing a clinical decision rule versus usual care to risk stratify children for intraabdominal injury after blunt torso trauma. Acad Emerg Med (2013) 0.81
Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann Intern Med (2016) 0.81
Prevalence and use of complementary health approaches among women with chronic pelvic pain in a prospective cohort study. Pain Med (2014) 0.81
Factors associated with seeking treatment for urinary incontinence during the menopausal transition. Obstet Gynecol (2015) 0.81
Recruiting rural participants for a telehealth intervention on diabetes self-management. J Rural Health (2012) 0.81
The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women. J Gen Intern Med (2009) 0.81
Dose escalation during the first year of long-term opioid therapy for chronic pain. Pain Med (2014) 0.81
Association between vaginal birth after cesarean delivery and primary cesarean delivery rates. Obstet Gynecol (2013) 0.81
Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians. J Cancer Educ (2012) 0.81
Race/Ethnicity and pregnancy decision making: the role of fatalism and subjective social standing. J Womens Health (Larchmt) (2010) 0.81
Attitudes toward birth spacing among low-income, postpartum women: a qualitative analysis. Matern Child Health J (2012) 0.80
Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Obstet Gynecol (2007) 0.80
Predictors of postpartum sexual activity and function in a diverse population of women. J Midwifery Womens Health (2013) 0.80
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. Am Heart J (2006) 0.80
Assessment of the UVR protection provided by different tree species. Photochem Photobiol (2007) 0.80
Predictors of hysterectomy in women with common pelvic problems: a uterine survival analysis. J Am Coll Surg (2007) 0.79
Chemoprevention: drug pricing and mortality: the case of tamoxifen. Cancer (2006) 0.79
Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis. Med Care (2008) 0.79
Predictors of impact of vaginal symptoms in postmenopausal women. Menopause (2016) 0.78
Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care (2012) 0.78
Prevalence and incidence of urinary incontinence in a diverse population of women with noncancerous gynecologic conditions. Female Pelvic Med Reconstr Surg (2010) 0.78
Perceptions of prenatal testing for birth defects among rural Latinas. Matern Child Health J (2007) 0.78
Symptom resolution after hysterectomy and alternative treatments for chronic pelvic pain: does depression make a difference? Am J Obstet Gynecol (2011) 0.78
On the declining health status of welfare caseloads: emerging dilemmas for serving the poor. Soc Work Public Health (2011) 0.78
Recurrence of Preterm Birth and Early Term Birth. Obstet Gynecol (2016) 0.78
Vitamin D response of older people in residential aged care to sunlight-derived ultraviolet radiation. Arch Osteoporos (2014) 0.77
Patient willingness to participate in a clinical trial with preimplantation genetic diagnosis. Fertil Steril (2007) 0.77
Prenatal Testing in the Genomic Age: Clinical Outcomes, Quality of Life, and Costs. Obstet Gynecol (2015) 0.77
Measurements of the UVR protection provided by hats used at school. Photochem Photobiol (2006) 0.77
Resource use for total and supracervical hysterectomies: results of a randomized trial. Obstet Gynecol (2004) 0.76